The same authors had previously showed a novel mechanism of action of the EGCG, which was able to promote the non-amyloidogenic processing of the APP in AD mice (Rezai-Zadeh et al., 2005; Obregon et al., 2006). This evidence concerns the gene APP and Alzheimer disease.